SOURCE: BioBridges

BioBridges logo

February 12, 2015 08:00 ET

BioBridges Announces Historic Growth

BOSTON, MA--(Marketwired - February 12, 2015) - BioBridges, a leading clinical consulting company servicing the pharma, biotech, and medical device industries, announces 50.4% year over year top line growth for 2014. Growth is attributed to the evolving marketplace and increasing demand for consulting services. The results stem from continued expansion into NJ, NY, PA and West Coast markets, as well as the company's long standing Boston area performance.

The company, founded in 2005, retains key consulting staff and clients, while attracting and developing long term relationships. Many BioBridges consultants have been with the company for 5-10 years, offering clients multiple opportunities to access and retain their expertise as needed.

"This level of growth is a report card on quality, efficiency, positive impact and is ultimately the value BioBridges brings. Our long time staff and consultants team up to foster enduring, critical client relationships," said Jeff Souza, BioBridges CEO and Partner. "BioBridges is simply answering the greater call from the marketplace to expand its reach by attracting and retaining highly sought after industry professionals. This is a trend for which we see even more growth in 2015."

"Our impressive growth is a direct reflection of the incredible value our people contribute," said Jason Falchuk, Managing Partner. "More and more people are choosing our experienced and dedicated career representation and management. As a result, BioBridges has become home to the career consultant."

About BioBridges

BioBridges represents and manages the careers of experienced, highly sought after industry professionals who make an immediate, positive impact on the pharmaceutical, biotech, and medical device programs they serve.

Contact Information